RAPT: RAPT Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 144.50
Enterprise Value ($M) 99.18
Book Value ($M) 130.84
Book Value / Share 3.75
Price / Book 1.10
NCAV ($M) 123.38
NCAV / Share 3.53
Price / NCAV 1.17

Profitability (mra)
Return on Invested Capital (ROIC) -0.86
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.54

Liquidity (mrq)
Quick Ratio 7.01
Current Ratio 7.01

Balance Sheet (mrq) ($M)
Current Assets 148.36
Assets 155.82
Liabilities 24.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -127.06
Net Income -116.80

Cash Flow Statement (mra) ($M)
Cash From Operations -97.05
Cash from Investing 104.13
Cash from Financing 1.45

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Deep Track Capital, LP 5.22 -9.91
02-14 13G/A Price T Rowe Associates Inc /md/ 9.90 -4.02
02-14 13G/A Redmile Group, LLC 9.90 2.64
02-14 13G/A Perceptive Advisors Llc 6.20 18.96
02-13 13G Vanguard Group Inc 5.98
02-09 13G/A Fmr Llc 11.17 -2.14
01-26 13G/A BlackRock Inc. 7.10 28.87
01-23 13G/A State Street Corp 4.23 -25.05

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-07 10-K Form 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 91,832 465,979 19.71
2024-05-16 83,808 544,583 15.39
2024-05-15 106,270 1,206,430 8.81
2024-05-14 184,908 1,274,449 14.51
2024-05-13 87,687 1,074,251 8.16

(click for more detail)

Similar Companies
PWUP – PowerUp Acquisition Corp. QTTB – Q32 Bio Inc.
RANI – Rani Therapeutics Holdings, Inc. RCKT – Rocket Pharmaceuticals, Inc.
RLAY – Relay Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io